← Open Payments lookup

GINA MANGIN: Open Payments

NPI 1861450553 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$62,855 in 167 payments from 19 companies in 2025. Trend: 2023 $71,492 · 2024 $69,680 · 2025 $62,855

Speaker / faculty: $28,440Consulting: $19,732Travel & lodging: $10,056Food & beverage: $4,443Education: $184
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.38$14,710
GENZYME CORPORATION18$12,366
Incyte Corporation26$11,647
ABBVIE INC.25$11,168
Novartis Pharmaceuticals Corporation11$6,520
Eli Lilly and Company3$3,182
UCB, Inc.3$1,223
Janssen Biotech, Inc.7$480
Galderma Laboratories, L.P.7$377
LEO Pharma Inc.8$367

Products named: DUPIXENT, SKYRIZI, OPZELURA, EBGLYSS, RINVOQ, Bimzelx, TREMFYA, NEMLUVIO.

Industry payments across FL — which companies pay providers there.